MedTrace Logo

To Evaluate the Immunogenicity and Safety of Sequential Immunization Schedules of Sabin IPV and bOPV

NCT04054492 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 604

Last updated 2019-08-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate the immunogenicity and safety of sequential immunization schedules of Sabin IPV and bOPV.

Conditions

  • Vaccination
  • Reaction - Vaccine

Interventions

BIOLOGICAL

Sabin-IPV+bOPV+bOPV

202 subjects were vaccinated with 1 dose of Sabin-IPV and 2 doses of bOPV at their age of 2/3/4 months old, respectively

BIOLOGICAL

Sabin-IPV+Sabin-IPV+bOPV

197 subjects were vaccinated with 2 doses of Sabin-IPV and 1 dose of bOPV at their age of 2/3/4 months old, respectively

BIOLOGICAL

Sabin-IPV+Sabin-IPV+Sabin-IPV

205 subjects were vaccinated with 3 doses of Sabin-IPV at their age of 2/3/4 months old, respectively

Sponsors & Collaborators

  • Inner Mongolia Autonomous Region Center for Diseases Prevention and Control

    collaborator UNKNOWN

  • Shaanxi Provincial Center for Disease Control and Prevention

    collaborator OTHER

  • Hubei Provincial Center for Disease Control and Prevention

    collaborator OTHER

  • Peking University

    collaborator OTHER

  • China National Biotec Group Company Limited

    lead INDUSTRY

Principal Investigators

  • Shaohong Yan · Inner Mongolia Autonomous Region Center for Diseases Prevention and Control

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Days
Max Age
89 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2019-01-25
Completion
2019-06-12

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04054492 on ClinicalTrials.gov